Genus PLC (GNS)

Industry Biotechnology


This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

2,050.00p

Buy

2,070.00p

arrow-up45.00p (+2.23%)

Prices updated at 25 Oct 2024, 16:35 BST
| Prices minimum 15 mins delay
|
Prices in GBX

Genus PLC focusses on the healthcare sector. It specializes in providing genetic products intended for animals, which allow farmers to produce an enhanced quality of milk products.

Income statement

20232024
690m669m
188m179m
44m31m
6.384.64
33m8m
97m74m
Sales, General and administrative104m109m
Interest expenses14m21m
Provision for income taxes8m3m
Operating expenses144m148m
Income before taxes39m6m
Net income available to common shareholders33m8m
0.510.12
Net interest income-14m-18m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)0.5060.119
Free cash flow per share0.23030.0771
Book value/share8.68498.2616
Debt equity ratio0.3826840.501751

Balance sheet

20232024
Current assets259m271m
Current liabilities147m151m
Total capital765m771m
Total debt232m291m
Total equity569m543m
Total non current liabilities--
Loans196m228m
Total assets1,008m1,029m
Total liabilities--
Cash and cash equivalents36m43m
Common stock66m66m

Cash flow

20232024
Cash at beginning of period39m36m
Cash dividends paid-21m-21m
15m5m
Investments (gains) losses-31m-19m
36m43m
Net income--
50m30m
-35m-25m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2024 Morningstar. All rights reserved.